Prognostic factors in upper urinary tract urothelial carcinomas: A comprehensive review of the current literature

Giovanni Lughezzani, Maximilian Burger, Vitaly Margulis, Surena F. Matin, Giacomo Novara, Morgan Roupret, Shahrokh F. Shariat, Christopher G. Wood, Richard Zigeuner

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

Context: The heterogeneity of upper tract urothelial carcinoma (UTUC) biology and prognosis, as well as the presence of different treatment options, makes the clinical decision-making process extremely challenging. Objective: Provide an overview of the currently available prognostic factors for UTUC, focusing on clinical and pathologic characteristics, as well as on molecular markers. Evidence acquisition: A systematic literature search was conducted using the PubMed, Scopus, and Embase databases to identify original articles, review articles, and editorials regarding prognostic factors in patients with UTUC. Keywords included urothelial carcinoma, renal pelvis, ureter, upper urinary tract urothelial carcinoma, upper urinary tract transitional cell carcinoma, prognosis, prognostic factors, markers, and survival. Articles published between 2000 and 2011 were reviewed and selected with the consensus of all the authors. Evidence synthesis: Prognostic factors can be divided into four different categories: preoperative/clinical factors, intraoperative/ surgical factors, postoperative/pathologic factors, and molecular markers. Because of the rarity of the disease, only a small amount of level 1 evidence information from prospective randomized trials is available. Conversely, several single-institutional and multi-institutional studies have been published providing level 3 evidence information on various prognostic factors. Tumor stage and grade represent the best-established predictors of prognosis in patients with UTUC, but controversies still exist regarding the prognostic impact of tumor location and tumor necrosis. Several promising biomarkers have also been evaluated, but further studies evaluating their prognostic role are still needed. Finally, few prognostic models have been developed to provide clinicians with accurate estimates of the outcome of interest. Conclusions: In the past few years, several prognostic factors have been identified to help clinicians dealing with patients with UTUC in the decision-making process. However, well-designed multi-institutional studies are still needed to provide stronger evidence and to promote the use of these prognostic factors in clinical practice.

Original languageEnglish (US)
Pages (from-to)100-114
Number of pages15
JournalEuropean Urology
Volume62
Issue number1
DOIs
StatePublished - Jul 2012

Fingerprint

Urinary Tract
Carcinoma
Neoplasms
Kidney Pelvis
Transitional Cell Carcinoma
Ureter
PubMed
Consensus
Decision Making
Necrosis
Biomarkers
Databases
Survival

Keywords

  • Prognosis
  • Prognostic factors
  • Survival
  • Upper tract urothelial carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Prognostic factors in upper urinary tract urothelial carcinomas : A comprehensive review of the current literature. / Lughezzani, Giovanni; Burger, Maximilian; Margulis, Vitaly; Matin, Surena F.; Novara, Giacomo; Roupret, Morgan; Shariat, Shahrokh F.; Wood, Christopher G.; Zigeuner, Richard.

In: European Urology, Vol. 62, No. 1, 07.2012, p. 100-114.

Research output: Contribution to journalArticle

Lughezzani, G, Burger, M, Margulis, V, Matin, SF, Novara, G, Roupret, M, Shariat, SF, Wood, CG & Zigeuner, R 2012, 'Prognostic factors in upper urinary tract urothelial carcinomas: A comprehensive review of the current literature', European Urology, vol. 62, no. 1, pp. 100-114. https://doi.org/10.1016/j.eururo.2012.02.030
Lughezzani, Giovanni ; Burger, Maximilian ; Margulis, Vitaly ; Matin, Surena F. ; Novara, Giacomo ; Roupret, Morgan ; Shariat, Shahrokh F. ; Wood, Christopher G. ; Zigeuner, Richard. / Prognostic factors in upper urinary tract urothelial carcinomas : A comprehensive review of the current literature. In: European Urology. 2012 ; Vol. 62, No. 1. pp. 100-114.
@article{80e455c94dc346609586ec8bbcfbdcc8,
title = "Prognostic factors in upper urinary tract urothelial carcinomas: A comprehensive review of the current literature",
abstract = "Context: The heterogeneity of upper tract urothelial carcinoma (UTUC) biology and prognosis, as well as the presence of different treatment options, makes the clinical decision-making process extremely challenging. Objective: Provide an overview of the currently available prognostic factors for UTUC, focusing on clinical and pathologic characteristics, as well as on molecular markers. Evidence acquisition: A systematic literature search was conducted using the PubMed, Scopus, and Embase databases to identify original articles, review articles, and editorials regarding prognostic factors in patients with UTUC. Keywords included urothelial carcinoma, renal pelvis, ureter, upper urinary tract urothelial carcinoma, upper urinary tract transitional cell carcinoma, prognosis, prognostic factors, markers, and survival. Articles published between 2000 and 2011 were reviewed and selected with the consensus of all the authors. Evidence synthesis: Prognostic factors can be divided into four different categories: preoperative/clinical factors, intraoperative/ surgical factors, postoperative/pathologic factors, and molecular markers. Because of the rarity of the disease, only a small amount of level 1 evidence information from prospective randomized trials is available. Conversely, several single-institutional and multi-institutional studies have been published providing level 3 evidence information on various prognostic factors. Tumor stage and grade represent the best-established predictors of prognosis in patients with UTUC, but controversies still exist regarding the prognostic impact of tumor location and tumor necrosis. Several promising biomarkers have also been evaluated, but further studies evaluating their prognostic role are still needed. Finally, few prognostic models have been developed to provide clinicians with accurate estimates of the outcome of interest. Conclusions: In the past few years, several prognostic factors have been identified to help clinicians dealing with patients with UTUC in the decision-making process. However, well-designed multi-institutional studies are still needed to provide stronger evidence and to promote the use of these prognostic factors in clinical practice.",
keywords = "Prognosis, Prognostic factors, Survival, Upper tract urothelial carcinoma",
author = "Giovanni Lughezzani and Maximilian Burger and Vitaly Margulis and Matin, {Surena F.} and Giacomo Novara and Morgan Roupret and Shariat, {Shahrokh F.} and Wood, {Christopher G.} and Richard Zigeuner",
year = "2012",
month = "7",
doi = "10.1016/j.eururo.2012.02.030",
language = "English (US)",
volume = "62",
pages = "100--114",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Prognostic factors in upper urinary tract urothelial carcinomas

T2 - A comprehensive review of the current literature

AU - Lughezzani, Giovanni

AU - Burger, Maximilian

AU - Margulis, Vitaly

AU - Matin, Surena F.

AU - Novara, Giacomo

AU - Roupret, Morgan

AU - Shariat, Shahrokh F.

AU - Wood, Christopher G.

AU - Zigeuner, Richard

PY - 2012/7

Y1 - 2012/7

N2 - Context: The heterogeneity of upper tract urothelial carcinoma (UTUC) biology and prognosis, as well as the presence of different treatment options, makes the clinical decision-making process extremely challenging. Objective: Provide an overview of the currently available prognostic factors for UTUC, focusing on clinical and pathologic characteristics, as well as on molecular markers. Evidence acquisition: A systematic literature search was conducted using the PubMed, Scopus, and Embase databases to identify original articles, review articles, and editorials regarding prognostic factors in patients with UTUC. Keywords included urothelial carcinoma, renal pelvis, ureter, upper urinary tract urothelial carcinoma, upper urinary tract transitional cell carcinoma, prognosis, prognostic factors, markers, and survival. Articles published between 2000 and 2011 were reviewed and selected with the consensus of all the authors. Evidence synthesis: Prognostic factors can be divided into four different categories: preoperative/clinical factors, intraoperative/ surgical factors, postoperative/pathologic factors, and molecular markers. Because of the rarity of the disease, only a small amount of level 1 evidence information from prospective randomized trials is available. Conversely, several single-institutional and multi-institutional studies have been published providing level 3 evidence information on various prognostic factors. Tumor stage and grade represent the best-established predictors of prognosis in patients with UTUC, but controversies still exist regarding the prognostic impact of tumor location and tumor necrosis. Several promising biomarkers have also been evaluated, but further studies evaluating their prognostic role are still needed. Finally, few prognostic models have been developed to provide clinicians with accurate estimates of the outcome of interest. Conclusions: In the past few years, several prognostic factors have been identified to help clinicians dealing with patients with UTUC in the decision-making process. However, well-designed multi-institutional studies are still needed to provide stronger evidence and to promote the use of these prognostic factors in clinical practice.

AB - Context: The heterogeneity of upper tract urothelial carcinoma (UTUC) biology and prognosis, as well as the presence of different treatment options, makes the clinical decision-making process extremely challenging. Objective: Provide an overview of the currently available prognostic factors for UTUC, focusing on clinical and pathologic characteristics, as well as on molecular markers. Evidence acquisition: A systematic literature search was conducted using the PubMed, Scopus, and Embase databases to identify original articles, review articles, and editorials regarding prognostic factors in patients with UTUC. Keywords included urothelial carcinoma, renal pelvis, ureter, upper urinary tract urothelial carcinoma, upper urinary tract transitional cell carcinoma, prognosis, prognostic factors, markers, and survival. Articles published between 2000 and 2011 were reviewed and selected with the consensus of all the authors. Evidence synthesis: Prognostic factors can be divided into four different categories: preoperative/clinical factors, intraoperative/ surgical factors, postoperative/pathologic factors, and molecular markers. Because of the rarity of the disease, only a small amount of level 1 evidence information from prospective randomized trials is available. Conversely, several single-institutional and multi-institutional studies have been published providing level 3 evidence information on various prognostic factors. Tumor stage and grade represent the best-established predictors of prognosis in patients with UTUC, but controversies still exist regarding the prognostic impact of tumor location and tumor necrosis. Several promising biomarkers have also been evaluated, but further studies evaluating their prognostic role are still needed. Finally, few prognostic models have been developed to provide clinicians with accurate estimates of the outcome of interest. Conclusions: In the past few years, several prognostic factors have been identified to help clinicians dealing with patients with UTUC in the decision-making process. However, well-designed multi-institutional studies are still needed to provide stronger evidence and to promote the use of these prognostic factors in clinical practice.

KW - Prognosis

KW - Prognostic factors

KW - Survival

KW - Upper tract urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84861631137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861631137&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2012.02.030

DO - 10.1016/j.eururo.2012.02.030

M3 - Article

C2 - 22381168

AN - SCOPUS:84861631137

VL - 62

SP - 100

EP - 114

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 1

ER -